Related Experiment Video
Updated: Mar 26, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mycoplasma pneumoniae as a trigger for Henoch-Schönlein purpura in children
Elżbieta Kuźma-Mroczkowska1, Małgorzata Pańczyk-Tomaszewska1, Agnieszka Szmigielska1
1Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
Abstract:
Mycoplasma pneumoniae is one of the most common causes of respiratory tract infections in children. Extrapulmonary manifestations are seen in up to 25% of infected patients. Extrapulmonary complications are associated with the central nervous system, gastrointestinal tract, skin changes, myocarditis, pericarditis, hemolytic anemia, thrombocytopenia and thrombosis. The majority of extrapulmonary symptoms are associated with skin changes such as exanthematous skin eruptions, erythema nodosum, urticaria, Stevens-Jonson syndrome. M. pneumoniae stimulates production of the interleukins and tumor necrosis factor (TNF) α and can cause vasculitis. Henoch-Schönlein purpura (HSP) is a leucoclastic vasculitis that affects small vessels. Clinical manifestations of HSP include typical rash, arthritis, gastrointestinal and sometimes renal involvement. The main feature in HSP is abnormal IgA deposits in vessel walls. Circulating abnormal glycosylated IgA 1 and IgG antibodies form immune complexes: IgA1-IgG and anti-IgA 1. Immune complexes activate cytokines, parts of complement and influence directly the endothelium. We report cases of three children with Henoch-Schönlein purpura with prolonged and recurrent skin and joint changes. The serological analysis (positive serum IgM) confirmed Mycoplasma pneumoniae infection. Treatment with clarithromycin caused complete regression of disease. We suggest that in the case of prolonged symptoms of vasculitis due to Henoch-Schönlein purpura, Mycoplasma pneumonia infection may be a potential cause of exacerbation of the disease.
Insights
Mycoplasma pneumoniae infection can trigger Henoch-Schönlein purpura (HSP) in children, leading to prolonged skin and joint issues. Antibiotic treatment resolved symptoms, suggesting a link between this infection and HSP exacerbations.
Area of Science:
- Pediatrics
- Infectious Diseases
- Rheumatology
Background:
- Mycoplasma pneumoniae is a common pediatric respiratory pathogen.
- Extrapulmonary manifestations occur in up to 25% of M. pneumoniae infections, including skin changes and vasculitis.
- Henoch-Schönlein purpura (HSP) is a small vessel vasculitis characterized by IgA deposition.
Observation:
- Three children presented with recurrent Henoch-Schönlein purpura, exhibiting prolonged skin and joint symptoms.
- Serological analysis confirmed Mycoplasma pneumoniae infection in these patients.
- The observed vasculitis involved IgA immune complex deposition, consistent with HSP.
Findings:
- Mycoplasma pneumoniae infection was identified as a potential trigger for Henoch-Schönlein purpura exacerbations.
- Treatment with clarithromycin resulted in complete disease regression in the affected children.
- This suggests a causal link between M. pneumoniae and prolonged or recurrent HSP symptoms.
Implications:
- Mycoplasma pneumoniae should be considered in the differential diagnosis of prolonged or recurrent Henoch-Schönlein purpura in children.
- Early identification and treatment of M. pneumoniae may prevent severe or persistent vasculitic manifestations.
- Further research is warranted to elucidate the precise mechanisms linking M. pneumoniae to HSP pathogenesis.
Related Concept Videos
Atypical Pneumonia
Nephrotic Syndrome I : Introduction
Acute Pyelonephritis I: Introduction
Peptic Ulcer
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
